Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Psychiatry and Behavioral HealthAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Factors associated with age at natural menopause in a multiethnic sample of midlife women.Am J Epidemiol. 2001; 153: 865-874
- Duration of the menopausal transition is longer in women with young age at onset: the multi-ethnic Study of Women’s Health Across the Nation.Menopause N Y N. 2017; 24: 142-149
- The Seattle Midlife Women’s Health Study: a longitudinal prospective study of women during the menopausal transition and early postmenopause.Womens Midlife Health. 2016; 2: 6
- Major depression during and after the menopausal transition: study of women’s health across the nation (SWAN).Psychol Med. 2011; 41: 1879-1888
- Risk factors for major depression during midlife among a community sample of women with and without prior major depression: Are they the same or different?.Psychol Med. 2015; https://doi.org/10.1017/S0033291714002773
- Longitudinal pattern of depressive symptoms around natural menopause.JAMA Psychiatry. 2014; 71: 36-43
- Risk for new onset of depression during the menopausal transition: the harvard study of moods and cycles.Arch Gen Psychiatry. 2006; 63: 385-390
- Schizophrenia during Menopausal Transition.Ment Health Fam Med. 2016; 12https://doi.org/10.25149/1756-8358.1202005
- Menopause and schizophrenia.Menopause Int. 2012; 18: 10-14
- Risk of psychiatric disorders following symptomatic menopausal transition.Medicine (Baltimore). 2016; 95: e2800
- Menopause and illness course in bipolar disorder: a systematic review.Bipolar Disord. 2017; 19: 434-443
- Bipolar disorder in the menopausal transition.Curr Psychiatry Rep. 2019; 21: 130
- Does risk for anxiety increase during the menopausal transition? Study of Women’s Health Across the Nation.Menopause. 2013; 20: 488-495
- Anxiety disorders among women: a female lifespan approach.FOCUS. 2017; 15: 162-172
- Anxiety as a risk factor for menopausal hot flashes: evidence from the penn ovarian aging cohort.Menopause. 2016; 23: 942-949
- Neurosteroids as regulators of neuroinflammation.Front Neuroendocrinol. 2019; 55https://doi.org/10.1016/j.yfrne.2019.100788
- Treating schizophrenia during menopause.Menopause. 2017; 24: 582-588
- Estrogens in schizophrenia: progress, current challenges and opportunities.Curr Opin Psychiatry. 2021; 34: 228-237
- Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model.Am J Psychiatry. 2015; 172: 227-236
- Menopause, ageing, and alcohol use disorders in women.Maturitas. 2018; 111: 100-109
- Changes in excessive alcohol use among older women across the menopausal transition: a longitudinal analysis of the Study of Women’s Health Across the Nation.Biol Sex Differ. 2020; 11: 37
- The impact of cannabis use on vasomotor symptoms, mood, insomnia and sexuality in perimenopausal and postmenopausal women: a systematic review.Climacteric J Int Menopause Soc. 2021; 24: 572-576
- Menopausal symptoms and higher risk opioid prescribing in a national sample of women veterans with chronic pain.J Gen Intern Med. 2019; 34: 2159-2166
- Eating disorders in midlife women: a perimenopausal eating disorder?.Maturitas. 2016; 85: 112-116
- Disorders of eating and body image during the menopausal transition: associations with menopausal stage and with menopausal symptomatology.Eat Weight Disord EWD. 2021; https://doi.org/10.1007/s40519-021-01141-4
- Consensus bundle on maternal mental health.Obstet Gynecol. 2017; 129: 422-430
- Screening for depression in adults: US preventive services task force recommendation statement.JAMA. 2016; 315: 380-387
- Obstetrician-gynecologists’ screening and management of depression during perimenopause.Menopause. 2020; 27: 393-397
- Assessment of perimenopausal depression: a review.J Affect Disord. 2019; 249: 216-222
- Executive summary of the stages of reproductive aging workshop + 10: Addressing the unfinished agenda of staging reproductive aging.J Clin Endocrinol Metab. 2012; https://doi.org/10.1210/jc.2011-3362
- Compounded bioidentical menopausal hormone therapy.Fertil Steril. 2012; 98: 308-312
- Development and validation of a new rating scale for perimenopausal depression—the Meno-D.Transl Psychiatry. 2018; 8: 123
- Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population.Ann Fam Med. 2010; 8: 348-353
- Guidelines for the evaluation and treatment of perimenopausal depression: summary and recommendations.J Womens Health. 2019; 28: 117-134
- Symptoms during the perimenopause: Prevalence, severity, trajectory, and significance in women’s lives.Am J Med. 2005; 118 (Elsevier Inc.;): 14-24https://doi.org/10.1016/j.amjmed.2005.09.031
- The Menopause Rating Scale (MRS) scale: a methodological review.Health Qual Life Outcomes. 2004; 2: 45
- A menopause-specific quality of life questionnaire: development and psychometric properties.Maturitas. 1996; 24: 161-175
- A factor analytic study of climacteric symptoms.J Psychosom Res. 1976; 20: 425-430
- Vasomotor symptoms across the menopause transition differences among women.Obstet Gynecol Clin North Am. 2018; 45: 629-640
- Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women.Sleep. 2008; 31: 979-990
- Hot flashes and awakenings among midlife women.Sleep. 2019; 42https://doi.org/10.1093/sleep/zsz131
- The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer.J Pain Symptom Manage. 2001; 22: 979-989
- The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response.Sleep. 2011; 34: 601-608
- Evaluation and management of sleep disturbance during the menopause transition.Semin Reprod Med. 2010; https://doi.org/10.1055/s-0030-1262900
- Menopause effects on verbal memory: findings from a longitudinal community cohort.J Clin Endocrinol Metab. 2013; 98: 3829-3838
- Memory functioning among midlife women: observations from the seattle midlife women’s health study.Menopause. 2000; 7: 257-265
- Menopause-associated symptoms and cognitive performance: results from the study of women’s health across the nation.Am J Epidemiol. 2010; 171: 1214-1224
- New onset executive function difficulties at menopause: a possible role for lisdexamfetamine.Psychopharmacology (Berl). 2015; 232: 3091-3100
- Lisdexamfetamine effects on executive activation and neurochemistry in menopausal women with executive function difficulties.Neuropsychopharmacol. 2017; 42: 437-445
- The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.J Am Geriatr Soc. 2005; 53: 695-699
- A review of attention-deficit/hyperactivity disorder in women and girls: uncovering this hidden diagnosis.Prim Care Companion CNS Disord. 2014; 16https://doi.org/10.4088/PCC.13r01596
- Relationship between sex hormones, reproductive stages and ADHD: a systematic review.Arch Womens Ment Health. 2021; https://doi.org/10.1007/s00737-021-01181-w
- Change in sexual functioning over the menopausal transition: results from the Study of Women’s Health Across the Nation.Menopause. 2017; 24: 379-390
- Factors associated with developing vaginal dryness symptoms in women transitioning through menopause: a longitudinal study.Menopause. 2018; 25: 1094-1104
- Thyroid disease in women at midlife.NEJM J Watch. 2014; 2014https://doi.org/10.1056/nejm-jw.NA34807
- Muscle and bone mass in middle-aged women: role of menopausal status and physical activity.J Cachexia Sarcopenia Muscle. 2020; 11: 698-709
- Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.J Clin Psychiatry. 2013; 74: 1010-1017
- Nonhormonal management of menopause-Associated vasomotor symptoms: 2015 position statement of the North American Menopause Society.Menopause. 2015; 22: 1155-1174
- Assessment and treatment of hot flushes and menopausal mood disturbance.Psychiatr Clin North Am. 2003; 26: 563-580
- Hutner L.A. Catapano L. Nagle-Yang S.M. Textbook of women’s reproductive mental health. 1st edition. American Psychiatric Association Publishing, 2021
- Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials.Ann Intern Med. 2002; 137: 805-813
- Black cohosh (Cimicifuga spp.) for menopausal symptoms.Cochrane Database Syst Rev. 2012; 9: CD007244
- Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms – an update on the evidence.Climacteric. 2021; 24: 109-119
- Comparison of vitex agnus-castus extracts with placebo in reducing menopausal symptoms: a randomized double-blind study.Korean J Fam Med. 2019; 40: 362-367
- What the Women’s Health Initiative has taught us about menopausal hormone therapy.Clin Cardiol. 2018; 41: 247-252
- The 2017 hormone therapy position statement of the North American Menopause Society.Menopause. 2017; 24: 728-753
- Efficacy of transdermal estradiol and micronized progesterone in the prevention of depressive symptoms in the menopause transition.JAMA Psychiatry. 2018; https://doi.org/10.1001/jamapsychiatry.2017.3998
- Efficacy of estradiol in perimenopausal depression: so much promise and so few answers.Depress Anxiety. 2015; 32: 539-549
- Antipsychotic response worsens with postmenopausal duration in women with schizophrenia.J Clin Psychopharmacol. 2016; 36: 580-587
- Moderators and mediators of antipsychotic response in delusional disorder: Further steps are needed.World J Psychiatry. 2020; 10: 34-45
- Treating schizophrenia at the time of menopause.Maturitas. 2012; 72: 117-120
- Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia.Psychoneuroendocrinology. 2010; 35: 1142-1147
- Effects of raloxifene on cognition, mental health, sleep and sexual function in menopausal women: a systematic review of randomized controlled trials.Maturitas. 2013; 75: 341-348
- Adjunct treatments for schizophrenia and bipolar disorder: what to try when you are out of ideas.Clin Schizophr Relat Psychoses. 2012; 5: 208-216
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
